PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
November 27, 2023Journal of the American Chemical Society68 citationsOpen Access

A Terrylene–Anthraquinone Dyad as a Chromophore for Photothermal Therapy in the NIR-II Window

ZWZehua WuMPMin PengCJChendong Ji

Key Points

Key points are not available for this paper at this time.

Abstract

A terrylenedicarboximide-anthraquinone dyad, FTQ, with absorption in the second near-infrared region (NIR-II) is obtained as a high-performance chromophore for photothermal therapy (PTT). The synthetic route proceeds by C-N coupling of amino-substituted terrylenedicarboximide (TMI) and 1,4-dichloroanthraquinone followed by alkaline-promoted dehydrocyclization. FTQ with extended π-conjugation exhibits an optical absorption band peaking at 1140 nm and extending into the 1500 nm range. Moreover, as determined by dielectric spectroscopy in dilute solutions, FTQ achieves an ultrastrong dipole moment of 14.4 ± 0.4 Debye due to intense intramolecular charge transfer. After encapsulation in a biodegradable polyethylene glycol (DSPE-mPEG2000), FTQ nanoparticles (NPs) deliver a high photothermal conversion efficiency of 49% under 1064 nm laser irradiation combined with excellent biocompatibility, photostability, and photoacoustic imaging capability. In vitro and in vivo studies reveal the great potential of FTQ NPs in photoacoustic-imaging-guided photothermal therapy for orthotopic liver cancer treatment in the NIR-II window.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Wu et al. (2023) studied this question.

synapsesocial.com/papers/69df27514fb243fc8e591a3ahttps://doi.org/10.1021/jacs.3c11314
Ask AI
Helpful
Bookmark
Share
View Full Paper